The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis - PubMed (original) (raw)
Comparative Study
The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis
M W Tas et al. AJNR Am J Neuroradiol. 1995 Feb.
Abstract
Purpose: To determine whether gadolinium can improve the sensitivity and specificity of MR imaging for the initial diagnosis of multiple sclerosis.
Methods: Patients (n = 57) with neurologic symptoms suggesting multiple sclerosis were studied prospectively. MR imaging consisted of T2-weighted and gadolinium-enhanced T1-weighted spin-echo images. Lumbar puncture was performed for cerebrospinal fluid analysis in 34 patients.
Results: After imaging, 17 patients (35%) had clinically definite multiple sclerosis. Cerebrospinal fluid examination had a sensitivity of 69% and specificity of 38%. Using liberal criteria, the sensitivity of T2-weighted MR imaging was 94% and the specificity 55%; using more strict criteria, the specificity increased to 65% with a sensitivity of 88%. Gadopentetate dimeglumine enhancement increased the specificity further to 80% with a loss of sensitivity (59%).
Conclusion: Gadolinium enhancement increases the specificity of MR imaging in the early diagnosis of multiple sclerosis.
Similar articles
- Gadolinium-enhanced T1-weighted versus T2-weighted imaging of scrotal disorders: is there an indication for MR imaging?
Müller-Leisse C, Bohndorf K, Stargardt A, Sohn M, Neuerburg J, Adam G, Wein B, Urhahn R, Günther RW. Müller-Leisse C, et al. J Magn Reson Imaging. 1994 May-Jun;4(3):389-95. doi: 10.1002/jmri.1880040326. J Magn Reson Imaging. 1994. PMID: 8061438 - MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
Low RN, Francis IR. Low RN, et al. AJR Am J Roentgenol. 1997 Oct;169(4):1051-9. doi: 10.2214/ajr.169.4.9308464. AJR Am J Roentgenol. 1997. PMID: 9308464 - Rectal carcinoma: prospective comparison of conventional and gadopentetate dimeglumine enhanced fat-suppressed MR imaging.
Okizuka H, Sugimura K, Yoshizako T, Kaji Y, Wada A. Okizuka H, et al. J Magn Reson Imaging. 1996 May-Jun;6(3):465-71. doi: 10.1002/jmri.1880060309. J Magn Reson Imaging. 1996. PMID: 8724412 - The evolution of multiple sclerosis lesions on serial MR.
Guttmann CR, Ahn SS, Hsu L, Kikinis R, Jolesz FA. Guttmann CR, et al. AJNR Am J Neuroradiol. 1995 Aug;16(7):1481-91. AJNR Am J Neuroradiol. 1995. PMID: 7484637 Free PMC article.
Cited by
- Design and development of an ethnically-diverse imaging informatics-based eFolder system for multiple sclerosis patients.
Ma KC, Fernandez JR, Amezcua L, Lerner A, Shiroishi MS, Liu BJ. Ma KC, et al. Comput Med Imaging Graph. 2015 Dec;46 Pt 2(Pt 2):257-68. doi: 10.1016/j.compmedimag.2015.09.007. Epub 2015 Oct 23. Comput Med Imaging Graph. 2015. PMID: 26564667 Free PMC article. - The relationship between enhanced plaques with Gadovist and Magnevist contrast brain magnetic resonance imaging and the neurological deficit in the acute phase of relapsing remitting multiple sclerosis.
Yaghoobi M, Harirchian MH, Firouznia K, Behzadi S, Hashemi H, Ghanaati H, Shakiba M, Jalali AH, Mohebbi S. Yaghoobi M, et al. Iran J Neurol. 2012;11(2):42-6. Iran J Neurol. 2012. PMID: 24250860 Free PMC article. - Updates on clinically isolated syndrome and diagnostic criteria for multiple sclerosis.
Marcus JF, Waubant EL. Marcus JF, et al. Neurohospitalist. 2013 Apr;3(2):65-80. doi: 10.1177/1941874412457183. Neurohospitalist. 2013. PMID: 23983889 Free PMC article. - [Diagnosis of multiple sclerosis 2010 revision of the McDonald criteria].
Klotz L, Gold R, Hemmer B, Korn T, Zipp F, Hohlfeld R, Kieseier BC, Wiendl H. Klotz L, et al. Nervenarzt. 2011 Oct;82(10):1302-9. doi: 10.1007/s00115-011-3283-x. Nervenarzt. 2011. PMID: 21681517 German. No abstract available. - Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Polman CH, et al. Ann Neurol. 2011 Feb;69(2):292-302. doi: 10.1002/ana.22366. Ann Neurol. 2011. PMID: 21387374 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical